Articles

Dave-DirectLinkTest

Teaser text goes hereTeaser text goes hereTeaser text goes hereTeaser text goes hereTeaser text goes hereTeaser text goes
hereTeaser text goes hereTeaser text goes hereTeaser text goes hereTeaser text goes hereTeaser text goes here
Teaser text goes hereTeaser text goes here

Read More

With pharma famine looming, Lilly relying on snack-size deals

Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year,
Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch on.

Read More